Effect of dapagliflozin on 24-hour glycemic variables in Japanese patients with type 2 diabetes mellitus receiving basal insulin supported oral therapy (DBOT): a multicenter, randomized, open-label, parallel-group study.
Akihiro KudoNoritaka MachiiToshio OnoHaruka SaitoYoshito OshiroRyu TakahashiKoichi OshiroYoshinobu TanedaMoritake HigaKen NakachiShusuke YagiHiroaki MasuzakiMasataka SataMichio ShimabukuroPublished in: BMJ open diabetes research & care (2023)
UMIN000019457.
Keyphrases
- open label
- type diabetes
- phase iii
- double blind
- phase ii
- clinical trial
- glycemic control
- phase ii study
- blood pressure
- study protocol
- placebo controlled
- stem cells
- randomized controlled trial
- cross sectional
- mesenchymal stem cells
- metabolic syndrome
- adipose tissue
- weight loss
- squamous cell carcinoma
- bone marrow
- cell therapy
- skeletal muscle